A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma
Hoosier Cancer Research Network
Hoosier Cancer Research Network
Post Graduate Institute of Medical Education and Research, Chandigarh
Fudan University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University Hospital, Lille
Medical University of Graz
University of Belgrade
National Cancer Institute, Egypt
University of California, San Francisco
Second Life Therapeutics
Konkuk University Medical Center
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.
Shanghai Zhongshan Hospital
NE Scientific INC
Case Comprehensive Cancer Center
Seattle Children's Hospital
Case Comprehensive Cancer Center
Rigshospitalet, Denmark
Tempest Therapeutics
Shanghai Zhongshan Hospital
National Cheng-Kung University Hospital
Tongji Hospital
Shanghai East Hospital
ImCare Biotech
Yunnan Cancer Hospital
H. Lee Moffitt Cancer Center and Research Institute
Shanghai Zhongshan Hospital